• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物电阻抗法是一种可靠的方法,可用于在静息和运动期间估计心输出量。

Bioreactance is a reliable method for estimating cardiac output at rest and during exercise.

机构信息

Institute of Neurosciences and Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Institute of Cellular Medicine, MoveLab, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

出版信息

Br J Anaesth. 2015 Sep;115(3):386-91. doi: 10.1093/bja/aeu560. Epub 2015 Feb 6.

DOI:10.1093/bja/aeu560
PMID:25659999
Abstract

BACKGROUND

Bioreactance is a novel noninvasive method for cardiac output measurement that involves analysis of blood flow-dependent changes in phase shifts of electrical currents applied across the thorax. The present study evaluated the test-retest reliability of bioreactance for assessing haemodynamic variables at rest and during exercise.

METHODS

22 healthy subjects (26 (4) yrs) performed an incremental cycle ergometer exercise protocol relative to their individual power output at maximal O2 consumption (Wmax) on two separate occasions (trials 1 and 2). Participants cycled for five 3 min stages at 20, 40, 60, 80 and 90% Wmax. Haemodynamic and cardiorespiratory variables were assessed at rest and continuously during the exercise protocol.

RESULTS

Cardiac output was not significantly different between trials at rest (P=0.948), or between trials at any stage of the exercise protocol (all P>0.30). There was a strong relationship between cardiac output estimates between the trials (ICC=0.95, P<0.001) and oxygen consumption (ICC=0.99, P<0.001). Stroke volume was also not significantly different between trials at rest (P=0.989) or during exercise (all P>0.15), and strong relationships between trials were found (ICC=0.83, P<0.001).

CONCLUSIONS

The bioreactance method demonstrates good test-retest reliability for estimating cardiac output at rest and during different stages of graded exercise testing including maximal exertion.

摘要

背景

生物电阻抗是一种新颖的非侵入性心输出量测量方法,涉及分析电流通过胸部时相位变化与血流变化之间的关系。本研究评估了生物电阻抗在评估静息和运动期间血流动力学变量的重测可靠性。

方法

22 名健康受试者(26(4)岁)在两次单独的试验(试验 1 和试验 2)中,根据最大耗氧量(Wmax)下的个体功率输出进行递增式功率自行车运动试验方案。参与者以 20%、40%、60%、80%和 90% Wmax 的五个体能进行 3 分钟的阶段运动。在静息和运动方案的整个过程中,评估血流动力学和心肺变量。

结果

在静息时(P=0.948)或在运动方案的任何阶段(所有 P>0.30),两次试验之间的心脏输出量没有显著差异。两次试验之间的心脏输出量估计值之间存在很强的相关性(ICC=0.95,P<0.001)和耗氧量(ICC=0.99,P<0.001)。在静息时(P=0.989)或运动时(所有 P>0.15),两次试验之间的每搏量没有显著差异,并且在两次试验之间发现了很强的相关性(ICC=0.83,P<0.001)。

结论

生物电阻抗方法在评估静息和不同分级运动试验阶段(包括最大用力)的心脏输出量方面具有良好的重测可靠性。

相似文献

1
Bioreactance is a reliable method for estimating cardiac output at rest and during exercise.生物电阻抗法是一种可靠的方法,可用于在静息和运动期间估计心输出量。
Br J Anaesth. 2015 Sep;115(3):386-91. doi: 10.1093/bja/aeu560. Epub 2015 Feb 6.
2
Comparison of cardiac output determined by bioimpedance and bioreactance methods at rest and during exercise.在静息和运动期间,通过生物阻抗和生物电抗方法测定的心输出量比较。
J Clin Monit Comput. 2012 Apr;26(2):63-8. doi: 10.1007/s10877-012-9334-4. Epub 2012 Jan 11.
3
Comparison of cardiac output estimates by bioreactance and inert gas rebreathing methods during cardiopulmonary exercise testing.心肺运动试验期间通过生物电阻抗法和惰性气体再呼吸法估算心输出量的比较。
Clin Physiol Funct Imaging. 2018 May;38(3):483-490. doi: 10.1111/cpf.12442. Epub 2017 Jun 2.
4
Test-Retest Reliability of Non-Invasive Cardiac Output Measurement during Exercise in Healthy Volunteers in Daily Clinical Routine.健康志愿者日常临床实践中运动时无创心输出量测量的重测信度。
Arq Bras Cardiol. 2019 Jul 10;113(2):231-239. doi: 10.5935/abc.20190116.
5
Reproducibility of Inert Gas Rebreathing Method to Estimate Cardiac Output at Rest and During Cardiopulmonary Exercise Stress Testing.在静息状态及心肺运动应激试验期间,采用惰性气体再呼吸法估算心输出量的可重复性。
Int J Sports Med. 2019 Feb;40(2):125-132. doi: 10.1055/a-0809-5408. Epub 2019 Jan 3.
6
Non-invasive assessment of cardiac output during exercise in healthy young humans: comparison between Modelflow method and Doppler echocardiography method.健康年轻人群运动期间心输出量的无创评估:Modelflow法与多普勒超声心动图法的比较
Acta Physiol Scand. 2003 Dec;179(4):361-6. doi: 10.1046/j.0001-6772.2003.01211.x.
7
A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise.一项在症状限制运动期间使用生物电抗技术进行无创心输出量的多中心研究。
J Card Fail. 2009 Oct;15(8):689-99. doi: 10.1016/j.cardfail.2009.04.005. Epub 2009 Jun 18.
8
Application of bioreactance for cardiac output assessment during exercise in healthy individuals.在健康个体运动期间应用生物电阻抗评估心输出量。
Eur J Appl Physiol. 2010 Jul;109(5):945-51. doi: 10.1007/s00421-010-1440-8. Epub 2010 Mar 25.
9
A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care.一种新的心力应激反应测试,旨在提高初级保健中心心力衰竭的诊断和监测。
ESC Heart Fail. 2018 Aug;5(4):703-712. doi: 10.1002/ehf2.12302. Epub 2018 Jun 26.
10
Reproducibility of the exponential rise technique of CO(2) rebreathing for measuring P(v)CO(2) and C(v)CO(2 )to non-invasively estimate cardiac output during incremental, maximal treadmill exercise.在递增式最大跑步机运动期间,用于测量混合静脉血二氧化碳分压(P(v)CO(2))和混合静脉血二氧化碳含量(C(v)CO(2))以无创估计心输出量的二氧化碳重呼吸指数上升技术的可重复性。
Eur J Appl Physiol. 2004 May;91(5-6):669-76. doi: 10.1007/s00421-003-1017-x. Epub 2003 Dec 3.

引用本文的文献

1
Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal study.基于人工智能的心力衰竭诊断和风险分层决策支持系统(STRATIFYHF)的临床验证:一项前瞻性、多中心纵向研究方案
BMJ Open. 2025 Jan 7;15(1):e091793. doi: 10.1136/bmjopen-2024-091793.
2
Lifestyle Intervention Improves Parasympathetic Activity in Hypertrophic Cardiomyopathy.生活方式干预可改善肥厚型心肌病患者的副交感神经活动。
Am J Lifestyle Med. 2024 May 16:15598276241253187. doi: 10.1177/15598276241253187.
3
Wearable Devices Based on Bioimpedance Test in Heart-Failure: Design Issues.
基于生物阻抗测试的心力衰竭可穿戴设备:设计问题
Rev Cardiovasc Med. 2024 Sep 9;25(9):320. doi: 10.31083/j.rcm2509320. eCollection 2024 Sep.
4
Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension.生物电阻抗法评估心输出量对肺动脉高压患者的随访缺乏可靠性。
PLoS One. 2024 May 20;19(5):e0298727. doi: 10.1371/journal.pone.0298727. eCollection 2024.
5
Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum.妊娠期及产褥期女性心血管生理学评估指南。
Am J Physiol Heart Circ Physiol. 2024 Jul 1;327(1):H191-H220. doi: 10.1152/ajpheart.00055.2024. Epub 2024 May 17.
6
Age, sex, endurance capacity, and chronic heart failure affect central and peripheral factors of oxygen uptake measured by non-invasive and continuous technologies: support of pioneer work using invasive or non-continuous measures.年龄、性别、耐力以及慢性心力衰竭会影响通过非侵入性和连续性技术测得的摄氧的中枢和外周因素:对采用侵入性或非连续性测量方法的先驱性研究的支持。
Front Sports Act Living. 2023 Sep 5;5:1218948. doi: 10.3389/fspor.2023.1218948. eCollection 2023.
7
Haemodynamic determinants of quality of life in chronic heart failure.慢性心力衰竭患者生活质量的血液动力学决定因素。
BMC Cardiovasc Disord. 2022 Sep 16;22(1):412. doi: 10.1186/s12872-022-02829-w.
8
Feasibility of the cardiac output response to stress test in suspected heart failure patients.疑似心力衰竭患者应激试验心输出量反应的可行性。
Fam Pract. 2022 Sep 24;39(5):805-812. doi: 10.1093/fampra/cmab184.
9
Bioreactance reliably detects preload responsiveness by the end-expiratory occlusion test when averaging and refresh times are shortened.当平均时间和刷新时间缩短时,生物电阻抗通过呼气末阻断试验能够可靠地检测前负荷反应性。
Ann Intensive Care. 2021 Aug 28;11(1):133. doi: 10.1186/s13613-021-00920-7.
10
Ventilatory and chronotropic incompetence during incremental and constant load exercise in end-stage renal disease: a comparative physiology study.终末期肾病递增和恒负荷运动中的通气和变时功能不全:比较生理学研究。
Am J Physiol Renal Physiol. 2020 Sep 1;319(3):F515-F522. doi: 10.1152/ajprenal.00258.2020. Epub 2020 Aug 3.